Literature DB >> 23014480

Prevalence, predictors and clinical impact of unique and multiple chronic total occlusion in non-infarct-related artery in patients presenting with ST-elevation myocardial infarction.

Yoann Bataille1, Jean-Pierre Déry, Eric Larose, Ugo Déry, Olivier Costerousse, Josep Rodés-Cabau, Stéphane Rinfret, Robert De Larochellière, Eltigani Abdelaal, Jimmy Machaalany, Gérald Barbeau, Louis Roy, Olivier F Bertrand.   

Abstract

OBJECTIVES: To investigate the predictors and impact on long-term survival of one chronic total occlusion (CTO) or multiple CTOs in patients presenting with ST-elevation myocardial infarction (STEMI).
DESIGN: Single-centre retrospective observational study.
SETTING: University-based tertiary referral centre. PATIENTS: Between 2006 and 2011, a total of 2020 consecutive patients referred with STEMI were categorised into single vessel disease, multivessel disease (MVD) without CTO, with one CTO or with multiple CTOs. INTERVENTION: Primary percutaneous coronary intervention. MAIN OUTCOME MEASURE: The primary end-point was the 1-year mortality.
RESULTS: The prevalence of single vessel disease, MVD without CTO, with one CTO or with multiple CTOs was 70%, 22%, 7.2% and 0.8%, respectively. Independent clinical predictors for the presence of CTO were cardiogenic shock (OR 5.05; 95% CI 3.29 to 7.64), prior myocardial infarction (OR 2.06; 95% CI 1.35 to 3.09), age >65 years (OR 1.94; 95% CI 1.40 to 2.71) and history of angina (OR 1.94; 95% CI 1.29 to 2.87). Mortality was worse in patients with multiple CTOs (76.5%) compared with those with one CTO (28.1%) or without CTO (7.3%) (p<0.0001). After adjustment for left ventricular ejection fraction and renal function, MVD was an independent predictor for 1-year mortality (HR: 1.81; 95% CI 1.18 to 2.77, p=0.007), but CTO was not (HR: 1.07; 95% CI 0.66 to 1.73, p=0.78).
CONCLUSIONS: Simple clinical factors are associated with the presence of CTO in non-infarct-related artery in patients presenting with STEMI. In these patients, long-term survival was independently associated with MVD, left ventricular ejection fraction and renal function, but not with CTO per se.

Entities:  

Mesh:

Year:  2012        PMID: 23014480     DOI: 10.1136/heartjnl-2012-302376

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  7 in total

Review 1.  Long-term clinical outcomes after percutaneous coronary intervention for chronic total occlusions.

Authors:  Spyretta Golemati; Elias A Sanidas; George D Dangas
Journal:  Curr Cardiol Rep       Date:  2014-02       Impact factor: 2.931

2.  Evaluation of Oxidative Status in Elderly Patients with Multiple Cerebral Infarctions and Multiple Chronic Total Coronary Occlusions.

Authors:  Xia Li; Dianxuan Guo; Youdong Hu; Ying Chen
Journal:  Dis Markers       Date:  2022-06-28       Impact factor: 3.464

3.  One-year mortality of patients with ST-Elevation myocardial infarction: Prognostic impact of creatinine-based equations to estimate glomerular filtration rate.

Authors:  Yoann Bataille; Olivier Costerousse; Olivier F Bertrand; Olivier Moranne; Hans Pottel; Pierre Delanaye
Journal:  PLoS One       Date:  2018-07-06       Impact factor: 3.240

4.  The Comparison of Long-Term Outcome Between Patients with Single and Multiple Coronary Chronic Total Occlusions After Percutaneous Coronary Intervention.

Authors:  Miaomiao Cao; Bolin Li; Qian Li; Chaofeng Sun
Journal:  Int J Gen Med       Date:  2022-01-20

Review 5.  The evidence base for revascularisation of chronic total occlusions.

Authors:  Alan Bagnall; Ioakim Spyridopoulos
Journal:  Curr Cardiol Rev       Date:  2014-05

6.  Two-vessel chronic total occlusion. Complete percutaneous revascularisation.

Authors:  Artur Dębski; Paweł Tyczyński; Maksymilian P Opolski; Mariusz Kłopotowski; Maciej A Karcz; Adam Witkowski
Journal:  Postepy Kardiol Interwencyjnej       Date:  2014-11-17       Impact factor: 1.426

7.  Five-Year Outcomes of Successful Percutaneous Coronary Intervention with Drug-Eluting Stents versus Medical Therapy for Chronic Total Occlusions.

Authors:  Seung Woon Rha; Byoung Geol Choi; Man Jong Baek; Yang Gi Ryu; Hu Li; Se Yeon Choi; Jae Kyeong Byun; Ahmed Mashaly; Yoonjee Park; Won Young Jang; Woohyeun Kim; Jah Yeon Choi; Eun Jin Park; Jin Oh Na; Cheol Ung Choi; Hong Euy Lim; Eung Ju Kim; Chang Gyu Park; Hong Seog Seo; Dong Joo Oh
Journal:  Yonsei Med J       Date:  2018-07       Impact factor: 2.759

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.